Updates are available Correction dated 2025-11-28
Click to view Correction: https://doi.org/10.1007/s12094-025-04116-4
-
Authors
Servitja, Sonia
Castro-Henriques, Maria
Álvarez-Busto, Iñaki
Díez-Franco, Carlota
Medina-Castillo, Alba
Algarra-García, Maria Asunción
López-Miranda, Elena
Lario-Martínez, Margaret
Luengo-Alcázar, Maria Isabel
Borregón, Miguel
Davó, Ana
Gasull-Delgado, Anna
Roque-García, Sara
Gonzaga-López, Ana
Poveda-Ferriols, Jesús Manuel
Pascal, Severine
Mitroi-Marinescu, Ana María
García-Escolano, Marta
Fernández-Carvajal, Asia
Ferrándiz-Huertas, Clotilde
Ferrer-Montiel, Antonio https://orcid.org/0000-0002-2973-6607
-
Funding
Funding for this research was provided by:
Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana (PROMETEO/2021/031)
Ministerio de Ciencia, Innovación y Universidades (PID2021-126423OB-C21)
Universidad Miguel Hernández
- License Information
-
More Information
Article History
Received: 18 August 2025
Accepted: 11 September 2025
First Online: 1 October 2025
Change Date: 26 November 2025
Change Type: Update
Change Details: The original online version of this article was revised: to include the contributions of author Clotilde Ferrándiz-Huertas and to correct the funding number.
Change Date: 28 November 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12094-025-04116-4
Declarations
:
: CFH and MGE are the employees and shareholders of Prospera Biotech. AFC and AFM are the inventors of patent EP3621950B1 protecting non-pungent vanilloid analogs, and shareholders and board members of Prospera Biotech.
: Authors declare that this study has been approved by the appropriate ethics committee and have, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its amendments.
: All participants provided signed informed consent.
: This study was presented at: (1) the Spanish Medical Oncology Congress 2024; (2) the San Antonio Breast Cancer Symposium 2024; and (3) posted in MedrXiv: .
